Life Science News

RSS

ScionxBio announces collaboration to develop long-acting xRNA therapeutics

ScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA therapeutics, distinguished by their extended durability profile, today announced that it has entered into a worldwide strategic collaboration and licensing agreement with Sanofi to develop and commercialize extended exposure versions of certain Sanofi mRNA candidates by leveraging ScionxBio's proprietary TERA® platform.

From ScionxBio 21 Oct 2026

Paternal age may influence sex-specific gene expression changes in embryos

When genes are "expressed," it is like reading an instruction manual to create things the body needs - such as proteins or RNA.

20 Oct 2026

Novel "Raman genome" concept enables rapid tracking of viruses

A research team led by Distinguished Professor Giuseppe Pezzotti at the Biomedical Engineering Center, Kansai Medical University, has demonstrated that differences in the molecular structures of viral RNA can be captured as "Raman barcodes," enabling the identification of 20 SARS-CoV-2 variants and subvariants.

20 Oct 2026

Scientists find a way to boost the body's natural viral defenses

Washington State University researchers have discovered how to "crank up" a natural defense system in the body to combat viral infection, potentially opening a new door for treating virus infections, cancer, neurological disorders and other diseases.

20 Oct 2026

S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial material for S2N’s first-in-human study in Australia.

20 Oct 2026

Discovery of new bacteria opens fresh avenues for prostate cancer research

University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients.

20 Oct 2026

New gene-editing platform gives doctors control over cell therapies

An Australian clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.

20 Oct 2026

Researchers capture clear images of complex cancer drug building enzyme

A joint research group led by Ryo Tanifuji and Hiroki Oguri from the University of Tokyo and Yoshikazu Tanaka from Tohoku University has successfully visualized SacC, an enzyme that plays a key role in building the complex five-ring core of safracin B.

19 Oct 2026

Researchers use AI to identify early-stage inhibitors for antiviral therapy

Viral infections can be difficult to treat as viruses evolve rapidly, allowing them to develop resistance to drugs designed to attack viral proteins directly.

19 Oct 2026

Silicone droplets or protein aggregates? Vision Analytical’s Raptor 1788 answers the prefilled syringe particle question at PDA Universe of Pre-Filled Syringes and Injection Devices 2026

Optimize subvisible particle analysis in prefilled syringes with the Raptor 1788, featuring high-resolution imaging and non-destructive testing capabilities.

From Vision Analytical Inc. 19 Oct 2026

Invisible no more: New treatment avenue unlocked for deadliest lung cancer

Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally.

16 Oct 2026

invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal

invIOs GmbH (“invIOs”), a privately held biotechnology company developing innovative cancer immunotherapies, today announced the publication of new clinical data with its autologous PBMC (peripheral blood mononuclear cell) therapy APN401 in the peer-reviewed journal, Molecular Therapy Oncology.

16 Oct 2026

Study identifies priority genes for safer prescribing in older Chinese patients

A research team has identified three genes that could help prioritize pharmacogenomic testing for older adults in China who receive multiple medications.

15 Oct 2026

Vegan honey could match powerful antimicrobial properties of mānuka

Vegan honey alternatives could be engineered to have similar antimicrobial properties to prized mānuka honey from New Zealand, according to research at Aston University.

15 Oct 2026

Researchers identify molecular pathway that improves ultrasound-based bone defect healing

Researchers from Capital Medical University, Beijing, China, have identified a CaN/NFATC3/Id3/E2A/Bmp4 signaling pathway that helps explain how low-intensity pulsed ultrasound (LIPUS) promotes bone regeneration.

15 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. partner to apply quantum optimization and AI to advance Alzheimer’s drug research and explore new applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

Leading life science organizations collaborate for second London Bio-Innovation Week

One Nucleus, The Society for Laboratory Automation and Screening (SLAS), and ELRIG today announced that they will be collaborating during the second London Bio-Innovation Week, to facilitate multi-event and community networking and partnering opportunities for life science companies, academic researchers, bio-entrepreneurs, investors and advisers.

From Society for Laboratory Automation and Screening (SLAS) 15 Oct 2026

New project receives $2.3 million to develop a database and AI model to identify therapeutic peptides

A group of scientists led by Joseph Brown, assistant professor at the Leslie Dan Faculty of Pharmacy, has received $2.3 million USD in funding to develop a database and AI training model to identify peptides with therapeutic potential.

14 Oct 2026

Sex hormones dictate how skin stem cells renew themselves

For a long time, differences between females and males were mainly associated with the reproductive organs. Yet organs that have nothing to do with reproduction, such as the skin, can also be shaped by sex.

14 Oct 2026

Novel gene rejuvenation therapy preserves cell identity while reversing age

Every organ and tissue progressively loses function and integrity as it ages. In fact, researchers have identified "hallmarks of aging" that not only present specific processes impacted by age, but are also thought of as levers that, if successfully targeted, could help turn back the aging clock and result in tissue rejuvenation.

14 Oct 2026